Abeona Therapeutics Inc Prix/Valeur
Quel est le Prix/Valeur de Abeona Therapeutics Inc?
Le Prix/Valeur de Abeona Therapeutics Inc est 3.44
Quelle est la définition de Prix/Valeur?
Le ratio cours / valeur comptable représente le rapport entre la valeur des actions d'une entreprise et la valeur comptable par action.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Prix/Valeur des entreprises dans Health Care secteur sur NASDAQ par rapport à Abeona Therapeutics Inc
Que fait Abeona Therapeutics Inc?
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Entreprises avec prix/valeur similaire à Abeona Therapeutics Inc
- Jabil Inc a Prix/Valeur de 3.44
- JFrog Ltd a Prix/Valeur de 3.44
- Dialog Semiconductor Plc a Prix/Valeur de 3.44
- Diamond Hill Investment a Prix/Valeur de 3.44
- QMX Gold a Prix/Valeur de 3.44
- Electrocomponents Plc a Prix/Valeur de 3.44
- Abeona Therapeutics Inc a Prix/Valeur de 3.44
- Ten Lifestyle Plc a Prix/Valeur de 3.44
- Pennar Industries a Prix/Valeur de 3.44
- Palladium One Mining a Prix/Valeur de 3.44
- Kalyani Steels a Prix/Valeur de 3.44
- Fate Therapeutics Inc a Prix/Valeur de 3.44
- Compagnie Financière Richemont SA a Prix/Valeur de 3.45